Autres langues LumiraDx Limited

Actions

Marché Fermé - OTC Markets Autres places de cotation 21:48:07 24/04/2024			Varia. 5j.	Varia. 1 janv.
0,017 ^USD	+13,33 %		-34,87 %	-72,97 %

08/01	Les plus fortes baisses de la mi-journée	MT
02/01	Wall Street s'apprête à ouvrir 2024 en baisse en raison de la hausse des prix du pétrole et en prévision des données sur l'industrie manufacturière et la construction	MT

Top Midday Decliners	08/01
Stocks Commence 2024 Bullish Rally: LMDX, HNRC, BULT, HALB, SPZI	08/01
LumiraDx Limited(OTCPK:LMDX.F) dropped from NASDAQ Composite Index	08/01
LumiraDx Announces its Securities will be Suspended from Trading on Nasdaq at the Open of Business on January 9th	05/01
Wall Street Set to Open 2024 Lower Amid Rise in Oil Prices, Ahead of Manufacturing, Construction Data	02/01
Top Premarket Decliners	02/01
Roche enters into a definitive agreement to acquire LumiraDx's Point of Care technology combining multiple diagnostic modalities on a single platform	02/01
Roche to buy part of LumiraDx diagnostics platform for $295 million	30/12
LumiraDx Agrees to Sell Point-of-Care Tech Platform to Roche	29/12
LumiraDx Announces Agreement to Sell its Cutting Edge Point of Care Technology Platform to Roche	29/12
LumiraDx : EXPLANATORY NOTE - Form 6-K	29/12
LumiraDx : EXPLANATORY NOTE - Form 6-K	11/12
Wall Street Set to Open Lower Friday as Investors Await Economic Data, Powell Speech	01/12
Investors Look Ahead to Powell Speech as US Futures Trend Lower Friday	01/12
Top Premarket Decliners	01/12
LumiraDx : EXPLANATORY NOTE - Form 6-K	21/11
LumiraDx Limited Announces Resignation of Lu Huang from the Board of Directors	07/11
LumiraDx : EXPLANATORY NOTE - Form 6-K	06/11
LumiraDx Limited Announces Board Appointments	06/11
LumiraDx Limited Appoints Veronique Ameye as the Company?s Chief Executive Officer and General Counsel, Effective as of November 1, 2023	06/11

Aucun résultat pour cette recherche